...
首页> 外文期刊>Molecular syndromology >Germline Mutations in >RASA1 Are Not Found in Patients with Klippel-Trenaunay Syndrome or Capillary Malformation with Limb Overgrowth
【24h】

Germline Mutations in >RASA1 Are Not Found in Patients with Klippel-Trenaunay Syndrome or Capillary Malformation with Limb Overgrowth

机译:在Klippel-Trenaunay综合征或伴有肢体过度生长的毛细血管畸形患者中未发现> RASA1 中的种系突变

获取原文

摘要

The RASA1 gene encodes p120RASGAP, a multidomain cytoplasmic protein that acts as a negative regulator of the RAS signalling pathway. Heterozygous loss-of-function RASA1 mutations were identified in patients with Parkes Weber syndrome and multifocal capillary malformations. This syndrome is characterised by a capillary blush on an extremity, arteriovenous microfistulas, and bony and soft tissue hypertrophy. The aim of this study was to test RASA1 in 2 disorders characterised by asymmetric limb enlargement and vascular malformations, namely Klippel-Trenaunay syndrome and regional capillary malformation with overgrowth. We did not identify any clear pathogenic change in these patients. Thus, besides clinical and radiological criteria, RASA1 testing constitutes an additional tool to differentiate Parkes Weber syndrome of capillary malformation-arteriovenous malformation (CM-AVM) from overlapping disorders.
机译:RASA1基因编码p120RASGAP,p120RASGAP是一种多域胞质蛋白,可作为RAS信号通路的负调节剂。在患有Parkes Weber综合征和多灶性毛细血管畸形的患者中鉴定出杂合功能丧失的RASA1突变。该综合征的特征是四肢毛细血管脸红,动静脉微瘘以及骨和软组织肥大。这项研究的目的是在两种以肢体不对称增大和血管畸形为特征的疾病中测试RASA1,即Klippel-Trenaunay综合征和过度生长的局部毛细血管畸形。我们没有在这些患者中发现任何明显的致病性变化。因此,除了临床和放射学标准外,RASA1测试还构成了区分毛细血管畸形-动静脉畸形(CM-AVM)的Parkes Weber综合征与重叠疾病的另一种工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号